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We report the longitudinal follow-up of Zika virus 
(ZIKV) RNA in semen of a traveller who developed ZIKV 
disease after return to the Netherlands from Barbados, 
March 2016. Persistence of ZIKV RNA in blood, urine, 
saliva and semen was followed until the loads reached 
undetectable levels. RNA levels were higher in semen 
than in other sample types and declined to undetect-
able level at day 62 post onset of symptoms.
Case report
In March 2016, a previously healthy man in his 50s, 
reported to the travel clinic at Erasmus MC, with 
arthralgia, conjunctivitis, fever (≥ 38.1°C) and rash. 
The patient had returned eight days earlier from a 
four day business trip to Barbados. He had been vac-
cinated according the Dutch guidelines for travellers, 
including for yellow fever (vaccinated in 2012). He 
remembered being bitten by mosquitoes during early 
mornings on the island. Four days after returning to 
the Netherlands he suffered from staggered joint pain 
in ankles, elbows and hand joints. Two days after the 
start of the joint pain he developed fever up to 38.5 °C, 
a total body macular rash, followed by conjunctivitis. 
The fever disappeared after three days as well as the 
joint pain, rash and conjunctivitis. No haematospermia 
was reported. The patient recovered completely. At the 
time of his visit in Barbados both ZIKV and chikungu-
nya virus (CHIKV) were circulating on the island.
Laboratory observations
Upon first presentation at the clinic, plasma and urine 
were collected. CHIKV RNA was not detectable by real-
time reverse-transcription polymerase chain reaction 
(RT-PCR) [1], while ZIKV RNA was detectable for two 
independent RT-PCR targets in plasma and urine [2], 
confirming ZIKV disease. The patient agreed to follow-
up sampling and ZIKV testing of blood, saliva, urine 
and semen until the sample type turned negative. 
Additional urine was collected and found positive for 
the most sensitive target at 6, 10, 13 and 19 days post 
onset of illness (dpi) (Figure).
Real-time RT-PCR analysis was validated according to 
ISO15189;2012 guidelines, briefly total nucleic acids 
were purified from 200 µL of plasma, saliva, urine or 
semen sample and eluted in a final volume of 100 μL 
using MagNaPure LC total nucleic acid isolation kit 
and the HP200 protocol (Roche Life Science, Almere 
the Netherlands). Subsequently, 8 μL of eluate in a 
final volume of 20 μL was used per reaction. Real-time 
RT-PCR was performed using the primers and probe 
set 1086/1162c/1107-FAM developed by Lanciotti et al. 
[2], and which annealed the most sensitive target men-
tioned above, and Fast Virus 1-Step Master Mix (Life 
technologies, Nieuwkerk a/d IJssel, the Netherlands) 
on a LC480-II (Roche), with 5 min 50 °C, 20 s 95 °C, and 
45 cycles of 3 s 95 °C and 30 s 60 °C as thermal profile. 
The real-time RT-PCR was internally controlled for inhi-
bition by addition of phocine distemper virus [3].
Saliva was collected at 6 and 10 dpi and was only posi-
tive at day 6. Additional plasma samples were taken at 
6 and 10 dpi and ZIKV genome levels turned undetect-
able at 10 dpi. Semen was collected at 10, 13, 19, 20, 
32, 34, 47 and 62 dpi and turned negative at the last 
sampling point.
Based on the semi-quantitative real-time RT-PCR data 
for the different sample types, the ZIKV RNA load 
appeared to be the highest in semen and remained 
higher in semen than in urine in the follow-up sam-
ples. Both urine and semen increased the window of 
ZIKV detection in clinical samples of this patient, with 
up to six-fold for semen vs plasma or saliva, and show 
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a slow decline versus plasma and saliva in ZIKV RNA 
levels with time.
Attempts to isolate virus from saliva at 6 dpi and from 
all the semen and urine samples failed. Enzyme-linked 
immunosorbent assay (ELISA; Euroimmun, Lübeck, 
Germany) testing on serum collected at 6 and 10 dpi 
demonstrated the presence of anti-ZIKV IgM in both 
samples and seroconversion for anti-ZIKV IgG. Virus 
neutralisation using a ZIKV isolate from Suriname gave 
a reciprocal neutralising antibody titre of 256 at 47 dpi. 
Background 
ZIKV is a mosquito-borne flavivirus that has emerged 
in South and Central America and the Caribbean since 
2015, affecting 39 countries in the region with an 
estimated 270,000 suspected and 40,000 confirmed 
cases as of 19 May 2016 [3]. Barbados reported its first 
three autochthonous ZIKV cases on 15 January 2016 [4] 
and has reported 317 suspected and seven confirmed 
cases since (status 19 May 2016 [3]). The association of 
ZIKV infection during pregnancy with microcephaly in 
newborns and other neurological disorders urged the 
World Health Organization (WHO) to declare the out-
break of microcephaly-associated ZIKV a Public Health 
Emergency of International Concern on 1 February 2016 
[5]. With the outbreak of ZIKV in some European over-
seas countries and territories the risk of importation 
of ZIKV to Europe due to intensive international travel 
is currently high [6]. In the diagnostic unit at Erasmus 
MC, 49 confirmed ZIKV patients have been diagnosed 
in the period between 29 November 2015 and 23 May 
2016, including two travellers returning from Barbados 
in March 2016 (A. van der Eijk, personal communica-
tion, May 2016).
Discussion
Aedes aegypti mosquitoes are the main vector for ZIKV 
transmission. However, the increasing import of ZIKV 
cases in non-endemic countries has put a previously 
obscure mode of non-mosquito-borne ZIKV transmis-
sion in the limelight: sexual transmission through 
infectious semen [7,8]. An increasing number of cases 
describing sexual transmission of ZIKV from sympto-
matic men-to-women or from symptomatic men-to-men 
have been reported from areas where Aedes aegypti is 
not present, including Europe [7,9-11]. Although sexual 
transmission seems to represent the greatest risk for 
ZIKV transmission in areas without competent mos-
quito vectors, little is known about the prevalence 
of ZIKV in semen of symptomatic and asymptomatic 
infected men, the kinetics of infectious ZIKV and ZIKV 
RNA in semen in both of these groups, the possible 
gonadotropism of ZIKV in men and the minimal infec-
tious dose for semen-borne transmission to men and 
women. Single time point sampling of semen reported 
the presence of viral RNA at 14 [7], 27 and 62 dpi [12] 
and isolation of virus 18 and 24 dpi [10].
An important implication of the teratogenicity of ZIKV 
and semen as source for ZIKV infection [13], is the 
necessity for protected sexual intercourse at least dur-
ing pregnancy for men returning from ZIKV endemic 
areas or when residing in those areas. The European 
Centre for Disease prevention and Control (ECDC) rec-
ommends that male travellers returning from areas 
with active transmission should consider using a con-
dom with a pregnant partner until the end of preg-
nancy, but should consider the use of a condom for at 
least one month upon return to reduce the potential 
risk of onward sexual transmission with non-pregnant 
female or male partners [14]. Some national guidelines 
[15-17] advise condom use for one to two months prob-
ably based on the very limited ZIKV isolation data that 
has been reported for semen up to 24 dpi [7,10]. 
In line with a report by Mansuy et al. [7], our data show 
higher ZIKV RNA loads in semen than in other sample 
types for our patient. Moreover in our study, the viral 
RNA loads in semen only slowly declined with time to 
undetectable levels at 62 dpi. Based on this observa-
tion and that of others, whereby another study reports 
a patient’s semen still positive for ZIKV RNA 62 dpi, 
however, with no end-point determination [12], the 
advice to use a condom with a non-pregnant partner for 
one month after return from an endemic area might be 
reconsidered to at least 90 days upon return (including 
the 62 days [12] and the subsequent maximum incuba-
tion time of 13 days [18]) as long as some of the crucial 
questions mentioned above have not been answered 
and a fully evidence-based recommendation on con-
dom use is not possible yet. Another implication is the 
need for review of inclusion criteria for sperm donation.
 
The higher ZIKV RNA load in semen than in urine sam-
ples taken at the same time points found here, has also 
been previously observed for two other patients [7,10]. 
Figure 
Semi-quantitative kinetics of Zika virus RNA loads 
in various types of clinical samples according to time 
post-disease onset, in a Dutch traveller returning from 
Barbados, March 2016*












This, together with the longevity of ZIKV RNA in semen 
indicates that semen should be taken into considera-
tion as a sample of choice for sensitive ZIKV diagnos-
tics with a broad detection window in males. While 
serology is usually the diagnostic method of choice in 
convalescent and asymptomatic patients with a sus-
pected arbovirus infection [19], flavivirus serology is 
highly complex due to co-circulation of cross-reactive 
other flaviviruses, the existence of cross-reactive fla-
vivirus vaccines and the occurrence of original anti-
genic sin [18]. Therefore molecular testing on semen 
might have an added value to serology in males up to 
2 months dpi.
Conclusions
We describe the longitudinal follow-up of the pres-
ence of ZIKV RNA in semen and other sample types in 
a returning traveller. Semi-quantitative ZIKV RNA levels 
were consistently higher in semen than in urine in the 
convalescent phase and slowly declined to an unde-
tectable level at 62 dpi. Testing of semen could have 
an added value to testing of urine and serology in men 
up to 2 months dpi. Although ZIKV was not isolated 
here, the use of condoms and the abstinence of semen 
donation up to 90 dpi as a precautionary measure to 
prevent sexual transmission of ZIKV, might need con-
sideration until a fully evidence-based assessment can 
be made based on data generated within larger patient 
datasets.
*Erratum
The Figure was corrected on 16 June 2016.
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